COVID-19  Health Evidence Summary No.76 by Millington, Kerry & Reddin, Samantha
   
1 
Evidence Summary 
y 
 
 
COVID-19  
Health Evidence Summary No.76 
Kerry Millington & Samantha Reddin 
Liverpool School of Tropical Medicine (LSTM) & Institute of Development Studies 
30 June 2020  
 
This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
29.06.2020 Childhood 
Multisystem 
Inflammatory 
Syndrome — 
A New 
Challenge in 
the Pandemic 
The New 
England 
Journal of 
Medicine | 
Editorial 
 As the Covid-19 pandemic 
has evolved, case reports 
have appeared describing 
children with unusual 
febrile illnesses that have 
features of Kawasaki’s 
disease, toxic shock 
syndrome, acute 
abdominal conditions, and 
encephalopathy, along 
with other reports of 
children with fever, 
elevated inflammatory 
markers, and multisystem 
involvement. It is now 
apparent that these 
reports were describing 
different clinical 
presentations of a new 
childhood inflammatory 
disorder. 
 Two reports now 
appearing in the Journal 
describe the epidemiology 
and clinical features of the 
children 
2 
new disorder in the United 
States. 
29.06.2020 Association of 
BMI and 
Obesity with 
Composite 
poor outcome 
in COVID-19 
adult patients: 
A Systematic 
Review and 
Meta-Analysis 
medRix (not 
peer 
reviewed) | 
pre-print 
 Based on a systematic 
literature search from 
PubMed and Embase 
database 
 Most studies were 
conducted in China 
(55.5%) with remaining 
studies from French, 
Germany, and United 
States 
 Conclusion: Obesity is a 
risk factor of composite 
poor outcome of COVID-
19. On the other hand, 
COVID-19 patients with 
composite poor outcome 
have higher BMI. BMI is 
an important routine 
procedure that should be 
assessed in the 
management of COVID-
19 patients and special 
attention should be given 
to patients with obesity 
obesity 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
29.06.2020 Statistics 
associated 
with the 
lethality of 
COVID-19 by 
age group and 
gender in 
Mexico 
medRix (not 
peer 
reviewed) | 
pre-print 
 Outcomes of 34,686 
SARS-CoV-2 confirmed 
cases analysed of patients 
attending the IMSS 
(Mexican Institute for 
National Insurance) from 
January 2 to June 23, 
2020. We calculated 
relative IFR by age group 
and gender and 
introduced the concept of 
adjusted lethalities, that 
can be used to project the 
burden of the disease for 
a population with different 
demographic 
characteristics. 
Data, 
age, 
gender 
3 
29.06.2020 Predictive 
model of 
COVID-19 
incidence and 
socioeconomic 
description of 
municipalities 
in Brazil 
medRix (not 
peer 
reviewed) | 
pre-print 
 The inhabitants in cities 
with reported cases of 
COVID-19 represent more 
than 73.1% of the 
Brazilian population. 
 Stratifying the age groups 
of the inhabitants and 
accounting for the 
percentage of women and 
men does not affect 
COVID-19 incidence 
(confirmed cases/100,000 
inhabitants). The 
demographic density, the 
MHDI and the per capita 
income of the 
municipalities with cases 
of COVID-19 do not affect 
disease incidence. 
 If conditions are 
maintained, our model 
predicts 2,358,703 
(2,172,930 to 2,544,477) 
cumulative cases on July 
25, 2020. 
Modelling, 
age, 
gender 
Social Science 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
29.06.2020 Digital 
tools 
against 
COVID-19: 
taxonomy, 
ethical 
challenges, 
and 
navigation 
aid 
Lancet digital 
health | 
Health policy 
 A typology of the primary 
digital public health 
applications that are in use are 
presented. These include 
proximity and contact tracing, 
symptom monitoring, 
quarantine control, and flow 
modelling. For each, we 
discuss context-specific risks, 
cross-sectional issues, and 
ethical concerns. 
 Recognising the need for 
practical guidance, we propose 
a navigation aid for policy 
makers and other decision 
makers for the ethical 
development and use of digital 
public health tools.  
Ethics, 
digital 
tools 
4 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article 
type 
Author(s) 
29.06.2020 Global Disparity and Solidarity in a 
Pandemic 
The Hastings 
Centre Report 
|Brief reflections 
Anita Ho,  Iulia 
Dascalu 
29.06.2020 What Could “Fair Allocation” during 
the Covid‐19 Crisis Possibly Mean in 
Sub‐Saharan Africa? 
The Hastings 
Centre Report | 
Essay 
Keymanthri 
Moodley, Laurent 
Ravez,  Adetayo 
Emmanuel 
Obasa  et al 
29.06.2020 Why N95 Should Be the Standard for 
All COVID-19 Inpatient Care 
Annals of internal 
medicine | Ideas 
and opinions 
Nhu Quyen Dau, 
29.06.2020 Impact of COVID-19 lockdown on 
routine immunisation in Karachi, 
Pakistan 
Lancet Global 
Health | 
Correspondance 
Subhash Chandir, 
Danya Arif Siddiqi, 
Hamidreza 
Setayesh, 
Aamir Javed Khan 
29.06.2020 Applications of digital technology in 
COVID-19 pandemic planning and 
response 
Lancet digital 
health | Viewpoint 
Sera 
Whitelaw,  Prof 
Mamas A Mamas, 
Prof Eric Topol,  
Harriette G C Van 
Spall 
29.06.2020 Child poverty, food insecurity, and 
respiratory health during the COVID-
19 pandemic 
Lancet respiratory 
medicine | 
spotlight 
Ian P Sinha, Alice R 
Lee et al 
  
26.06.2020 ‘The epidemic is growing very 
rapidly’: Indian government adviser 
fears coronavirus crisis will worsen 
Nature | News Jayaprakash Muliyil 
5 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
WHO sitreps WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-CoV-
2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
 COVID-
19 Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
  
Our World in 
Data 
  Singapore  Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 5050 
  UK  IFPRI 
COVID-19 
Policy 
Response 
Portal 
Cochrane       
CEBM, 
University of 
Oxford 
  US  COVID-19 
Primer 
Clinicaltrials.gov       
6 
Humanitarian 
Data 
Exchange 
     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability and 
inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashin
g in low 
resource 
settings 
  Coregroup 
IDDC 
7 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
    Social 
Development 
Direct C19 
blog series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
COVID-19 
Digest 
JAMA 
Network 
Norwegian 
Institute of Public 
Health 
    
UNHCR  South 
African 
Government 
The 
Lancet 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   medRxiv 
and 
bioRxiv 
(Preprints) 
 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
University 
Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources 
and Analyses of 
C19 Impact 
    
8 
World Bank   Science  Prevent 
Epidemics  
    
Our World in 
Data 
  Springer 
Nature 
      
COVID-19 
Narratives by 
David Nabarro 
  SSRN 
(Preprints)  
      
Reliefweb   Wiley       
Humanitarian 
OpenStreetMap 
Team 
          
Global 
Partnership for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
GISAID           
  
9 
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
30.06.2020 
1000 BST 
Clinical update: 
dexamethasone and 
hydroxychloroquine for 
treatment of severe 
COVID-19  
Webinar   African Academy of 
Sciences 
26.06.2020 
0900 to 
1030 EDT 
Monitoring and 
mitigating the collateral 
effects of COVID-19 
Online event 1h 30 CGD 
13 July 
3:00 PM – 
6:00 PM 
BST 
2020 UCL-Lancet 
Lecture: Global Health 
Preparedness by Dr 
Muhammad Pate, 
Global Director for 
Health, Nutrition and 
Population at the World 
Bank Group 
Online 
Lecture  
2 hour 
lecture, 1 
hour panel 
discussion 
UCL, The Lancet 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
24-
25.06.2020 
Africa’s leadership role 
in COVID-19 vaccine 
development and 
access 
Zoom webinar   African Union & Africa 
CDC 
Available 
now 
Standard precautions: 
Environmental cleaning 
and disinfection 
Online course 1 hour WHO 
10 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 2 
hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: Pandemics, 
Modelling and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn 
UNESCO UNITWIN 
Complex Systems 
Digital Campus/Open 
University 
12.05.2020 COVID-19 and 
maintaining quality 
essential health 
services  
Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr 
Peter Lachman, Dr 
Teri Rynolds & Dr Ed 
Kelley 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence Weeks 5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays 
at 1700 
CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open online 
brief with Dr David 
Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
11 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods for 
detection, prevention, 
response and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to COVID-
19: Real-time training 
for the coronavirus 
disease outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling the 
Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 Diagnostics 
and Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour weekly 
study 
FutureLearn 
University of 
Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
